臨床試驗

Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD

NCT：NCT07770867 · RECRUITING

NCT IDNCT07770867

狀態RECRUITING

開始日期2026-09-15

SponsorNeudive Inc. (INDUSTRY)

First posted2026-08-18

Last updated2026-09-17

簡要摘要

The purpose of this study is to evaluate the safety of NDTx-03 used together with treatment as usual (TAU) and to determine whether NDTx-03 plus TAU is more effective than TAU alone in improving social situation recognition and interaction in children and adolescents with autism spectrum disorder (ASD) or social communication disorder (SCD).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。